Over £2 million raised for new urgent care centre following appeal

Following an appeal from The Royal Marsden Cancer Charity to fund a new treatment and research facility, more than £2 million has been raised by partners from Goldman Sachs.

Oak Cancer Centre exterior

The Goldman Sachs Gives Centre for Urgent Care

The funds raised are for the Goldman Sachs Gives Centre for Urgent Care, a new department within the Oak Cancer Centre. This state-of-the-art facility at The Royal Marsden in Sutton is where patients who become unwell due to their symptoms, or who are experiencing side effects from treatment, will receive care from oncology experts. This model of care, developed by The Royal Marsden, means patients avoid unnecessarily being admitted to hospital.

The Royal Marsden Cancer Charity has committed to raising £70 million to fund the Oak Cancer Centre which will bring researchers, clinicians and patients together under one roof. It has been designed to encourage collaboration and to speed up the translation of world-leading research into breakthroughs in treatment and care for patients not just at The Royal Marsden, but throughout the UK and further afield.

Helping more patients with the latest treatments

The Goldman Sachs Gives Centre for Urgent Care will inform this innovative ‘bench-to-bedside’ drug development process as the side effects of patients attending the department will be closely monitored and treated, helping researchers assess new treatments. It will also expand and modernise the hospital’s existing service, quadrupling the number of patients who can be seen at any one time.

The generous donation from Goldman Sachs Gives was raised with the support of select partners. Goldman Sachs Gives is the bank’s donor-advised philanthropic fund. The partnership with the Charity, which launched in 2018, was spearheaded by Oak Cancer Centre Appeal Board member and Goldman Sachs partner, Richard Cormack.

Antonia Dalmahoy, Managing Director of The Royal Marsden Cancer Charity, said:

On behalf of the Charity, I would like to say a huge thank you to everyone who has supported us through Goldman Sachs Gives to help us reach this incredible milestone; we are so grateful for their tireless support. This generous donation takes us a big step closer to making the Oak Cancer Centre a reality, funding a department which will be a cornerstone of patient care within the facility

Instead of attending their local A&E, the Goldman Sachs Gives Centre for Urgent Care will offer patients with sudden or serious symptoms from treatment a discreet and dedicated space to be supported by cancer experts, ensuring the care and treatment they receive is specialised and tailored to them.

Richard Cormack, partner at Goldman Sachs and Appeal Board member for The Royal Marsden’s new Oak Cancer Centre, said:

I’m incredibly proud to support The Royal Marsden Cancer Charity and would like to say a massive thank you to my colleagues who have kindly donated to this appeal. It’s a real honour to know we’re funding a vital department in the Oak Cancer Centre, which will make a huge difference to the lives of cancer patients across the world.

Help build hope for people affected by cancer by supporting The Royal Marsden Cancer Charity’s appeal for a new research and treatment facility, the Oak Cancer Centre.

For further press information please contact [email protected] / 07584441446

About The Royal Marsden Cancer Charity

At The Royal Marsden we deal with cancer every day, so we understand how valuable life is. And when people entrust their lives to us, they deserve the very best. That’s why the pursuit of excellence lies at the heart of everything we do and why The Royal Marsden Cancer Charity exists.

Thanks to our supporters we continue to be there for everyone who needs us, raising money solely to support the hospital.  We ensure our nurses, doctors and research teams can provide the very best care and develop life-saving treatments, which are used across the UK and around the world.

From funding state-of-the-art equipment and ground-breaking research, to creating the very best patient environments, we will never stop looking for ways to improve the lives of people affected by cancer.